«78910111213›»Seite
13 articles with references, page 13 of 13

cme

Functional Bowel Disorders in Adults

Dtsch Arztebl Int 2012; 109(5): 83-93; DOI: 10.3238/arztebl.2012.0083

Häuser, W; Layer, P; Henningsen, P; Kruis, W

1.Hiller W, Rief W, Brähler E: Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 2006; 41: 704–12. CrossRef MEDLINE
2.Oberndorff-Klein Woolthuis AH, Brummer RJ, de Wit NJ, Muris JW, Stockbrügger RW: Irritable bowel syndrome in general practice: an overview. Scand J Gastroenterol Suppl 2004; 241: 17–22. CrossRef MEDLINE
3.Thompson WG, Heaton KW, Smyth GT, Smyth C: Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46: 78–82. CrossRef MEDLINE
4.Dhaliwal SK, Hunt RH: Doctor-patient interaction for irritable bowel syndrome in primary care: a systematic perspective. Eur J Gastroenterol Hepatol 2004; 16: 1161–6. CrossRef MEDLINE
5.Spiegel BM, Farid M, Esrailian E, Talley J, Chang L: Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010; 105: 848–58. CrossRef MEDLINE
6.Müller-Lissner SA, Pirk O: Irritable bowel syndrome in Germany. A cost of illness study. Eur J Gastroenterol Hepatol 2002; 14: 1325–9. CrossRef MEDLINE
7.Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V: Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466–79. CrossRef MEDLINE
8.Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J: Functional gallbladder and sphincter of oddi disorders. Gastroenterology 2006; 130: 1498–509. CrossRef MEDLINE
9.Bharucha AE, Wald A, Enck P, Rao S: Functional anorectal disorders. Gastroenterology 2006; 130: 1510–8. CrossRef MEDLINE
10.Bufler P, Gross M, Uhlig HH: Recurrent abdominal pain in childhood. Dtsch Arztebl Int 2011; 108(17): 295–304. VOLLTEXT
11.Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480–91. CrossRef MEDLINE
12.Layer P, Andresen V, Pehl C, Allescher H, Bischoff SC, Classen M, et al.: Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management. Z Gastroenterol 2011; 49: 237–93. CrossRef MEDLINE
13.Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al.: Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770–98. CrossRef MEDLINE
14. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, et al.: An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104(Suppl 1): 1–35. MEDLINE
15.Hausteiner-Wiehle C, Sattel H, Ronel J, Schäfert R, Herrmann M, Häuser W, Henningsen P (Steuerungsgruppe): Interdisziplinäre S3-Leitlinie zum Umgang mit Patienten mit nicht-spezifischen, funktionellen und somatoformen Körperbeschwerden. AWMF 2012; in press.
16.Tanaka Y, Kanazawa M, Fukudo S, Drossman DA: Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil 2011; 17: 131–9. CrossRef MEDLINE
17.Kato K, Sullivan PF, Evengård B, Pedersen NL: A population-based twin study of functional somatic syndromes. Psychol Med 2009; 39: 497–505. CrossRef MEDLINE
18.Saito YA: The role of genetics in IBS. Gastroenterol Clin North Am 2011; 40: 45–67. CrossRef MEDLINE
19.Wächtershäuser A, Stein JM: Nutritional factors and nutritional therapy for irritable bowel syndrome—what is worthwhile?
Z Gastroenterol 2008; 46: 279–91. MEDLINE
20.Chang L: The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011; 140: 761–5. CrossRef MEDLINE
21.Nicholl BI, Halder SL, Macfarlane GJ, Thompson DG, O’Brien S, Musleh M, McBeth J: Psychosocial risk markers for new onset irritable bowel syndrome—results of a large prospective population-based study. Pain 2008; 137: 147–55. CrossRef MEDLINE
22.Spiegel BM, Naliboff B, Mayer E, Bolus R, Gralnek I, Shekelle E: The effectiveness of a model physician-patient relationship versus usual care in irritable bowel syndrome (IBS): A randomized controlled trial Gastroenterology 2006; 130: Suppl 2: A–112.
23.Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M: Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 2008; 6: 545–55. CrossRef MEDLINE
24.Pimentel M, Lembo A, Chey WD, et al.: TARGET Study Group: Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364: 22–32. CrossRef MEDLINE
25.Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO: Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009 21; (1): CD006442. MEDLINE
e1. Andresen V, Keller J, Pehl C, Schemann M, Preiss J, Layer P: Clinical practice guideline: Irritable bowel syndrome–the main recommendations. Dtsch Arztebl Int 2011; 108(44): 751–60.
e2. Henningsen P, Zipfel S, Herzog W: Management of functional somatic syndromes. Lancet 2007; 369: 946–55.
e3. Häuser W, Eich W, Herrmann M, Nutzinger DO, Schiltenwolf M, Henningsen P: Fibromyalgia syndrome: classification, diagnosis, and treatment. Dtsch Arztebl Int 2009; 106(23): 383–91.
e4. Janssen HA, Muris JW, Knotterus JA: The clinical course and prognostic determinants of the irritable bowel syndrome: a literature review. Scand J Gastroenterol 1998; 33: 561–7.
e5. Schwille-Kiuntke J, Frick JS, Zanger P, Enck P: Post-infectious irritable bowel syndrome—a review of the literature. Z Gastroenterol 2011; 49: 997–1003.
e6. Spiller R, Garsed K: Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979–88.
e7. Levy RL, Whitehead WE, Walker LS, Von Korff M, Feld AD, Garner M, Christie D: Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol 2004; 99: 2442–51.
e8. Paras ML, Murad MH, Chen LP, et al.: Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis. JAMA 2009; 302: 550–61.
e9. Johannesson E, Simrén M, Strid H, Bajor A, Sadik R: Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2011; 106: 915–22.
e10. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ: Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004; 53: 1459–64.
e11. Hefner J, Rilk A, Herbert BM, Zipfel S, Enck P, Martens U: Hypnotherapy for irritable bowel syndrome-a systematic review. Z Gastroenterol 2009; 47: 1153–9.
e12. Lindfors P, Unge P, Arvidsson P, et al.: Effects of Gut-Directed Hypnotherapy on IBS in Different Clinical Settings-Results From Two Randomized, Controlled Trials. Am J Gastroenterol 2011 Oct 4. doi: 10.1038/ajg.2011.340 [Epub ahead of print].
e13. Lim B, Manheimer E, Lao L, et al.: Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2006 18; (4): CD005111 e12=e13
e14. Liu JP, Yang M, Liu YX, Wei ML, Grimsgaard S: Herbal medicines for treatment f irritable bowel syndrome. Cochrane Database Syst Rev 2006 J 25; (1): CD004116 [Epub ahead of print].
e15. Ford AC, Talley NJ, Spiegel BM, et al.: Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008 13; 337: a2313. doi: 10.1136/bmj.a2313.
e16. Moayyedi P, Ford AC, Talley NJ, et al.: The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59: 325–32.
e17. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P: Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009; 58: 367–7.
e18. Suares NC, Ford AC: Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 2011; 33: 895–901.
e19. Ford AC, Suares NC: Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011; 60: 209–18.